Cadila Healthcare’s Q1 consolidated net profit registers 15% growth

19 Jul 2011 Evaluate

Cadila Healthcare has reported results for the quarter ended June 30, 2011

The company’s net profit for the quarter has dipped by 23.01% at Rs 152.93 crore as compared to Rs 198.64 crore for the quarter ended June 30, 2010. Its total Income too has decreased by 1.07% to Rs 790.52 crore for the quarter under review from Rs 799.11 crore for the corresponding quarter of the previous year.

On Consolidated basis, the Group ‘s net profit has registered a gain of 15.38% at Rs 229.82 crore for the quarter ended June 30, 2011 as compared to Rs 199.18 crore for the quarter ended June 30, 2010. Its total Income has increased by 10.15% to Rs 1252 crore for the quarter from Rs 1136.65 crore for the similar quarter of the previous year.

Cadila Pharmaceuticals focuses on various areas, such as formulations (human & veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Zydus Lifesciences Share Price

1051.90 43.20 (4.28%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.